[HTML][HTML] Clinical application of mesenchymal stem cell in regenerative medicine: a narrative review

R Margiana, A Markov, AO Zekiy, MU Hamza… - Stem Cell Research & …, 2022 - Springer
The multipotency property of mesenchymal stem cells (MSCs) has attained worldwide
consideration because of their immense potential for immunomodulation and their …

Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine

E Karbassi, A Fenix, S Marchiano, N Muraoka… - Nature Reviews …, 2020 - nature.com
Our knowledge of pluripotent stem cell (PSC) biology has advanced to the point where we
now can generate most cells of the human body in the laboratory. PSC-derived …

Mechanisms of physiological and pathological cardiac hypertrophy

M Nakamura, J Sadoshima - Nature Reviews Cardiology, 2018 - nature.com
Cardiomyocytes exit the cell cycle and become terminally differentiated soon after birth.
Therefore, in the adult heart, instead of an increase in cardiomyocyte number, individual …

Regression of cardiac hypertrophy in health and disease: mechanisms and therapeutic potential

TG Martin, MA Juarros, LA Leinwand - Nature Reviews Cardiology, 2023 - nature.com
Left ventricular hypertrophy is a leading risk factor for cardiovascular morbidity and mortality.
Although reverse ventricular remodelling was long thought to be irreversible, evidence from …

Identification of long noncoding RNA H19 as a new biomarker and therapeutic target in right ventricular failure in pulmonary arterial hypertension

J Omura, K Habbout, T Shimauchi, WH Wu… - Circulation, 2020 - Am Heart Assoc
Background: Right ventricular (RV) function is the major determinant for both functional
capacity and survival in patients with pulmonary arterial hypertension (PAH). Despite the …

Physiological and pathological cardiac hypertrophy

I Shimizu, T Minamino - Journal of molecular and cellular cardiology, 2016 - Elsevier
The heart must continuously pump blood to supply the body with oxygen and nutrients. To
maintain the high energy consumption required by this role, the heart is equipped with …

Exosomal circHIPK3 released from hypoxia‐pretreated cardiomyocytes regulates oxidative damage in cardiac microvascular endothelial cells via the miR‐29a/IGF‐1 …

Y Wang, R Zhao, W Liu, Z Wang, J Rong… - Oxidative medicine …, 2019 - Wiley Online Library
Background/Aims. Circular RNAs (circRNAs) are a class of endogenous noncoding RNAs
that regulate gene expression in eukaryotes. Recently, exosomes from cardiomyocytes …

[HTML][HTML] Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function

MJ Birket, MC Ribeiro, G Kosmidis, D Ward… - Cell reports, 2015 - cell.com
Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-
CMs) is essential for their effective application in models of cardiac toxicity and disease …

Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A

L Barile, E Cervio, V Lionetti, G Milano… - Cardiovascular …, 2018 - academic.oup.com
Aims Cell therapy trials using cardiac-resident progenitor cells (CPCs) and bone marrow-
derived mesenchymal stem/progenitor cells (BMCs) in patients after myocardial infarction …

Alternative splicing isoforms in health and disease

HK Kim, MHC Pham, KS Ko, BD Rhee… - Pflügers Archiv-European …, 2018 - Springer
Alternative splicing (AS) of protein-coding messenger RNAs is an essential regulatory
mechanism in eukaryotic gene expression that controls the proper function of proteins. It is …